Correlation Between Ginkgo Bioworks and Silence Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ginkgo Bioworks and Silence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ginkgo Bioworks and Silence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ginkgo Bioworks Holdings and Silence Therapeutics PLC, you can compare the effects of market volatilities on Ginkgo Bioworks and Silence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ginkgo Bioworks with a short position of Silence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ginkgo Bioworks and Silence Therapeutics.

Diversification Opportunities for Ginkgo Bioworks and Silence Therapeutics

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ginkgo and Silence is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and Silence Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silence Therapeutics PLC and Ginkgo Bioworks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ginkgo Bioworks Holdings are associated (or correlated) with Silence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silence Therapeutics PLC has no effect on the direction of Ginkgo Bioworks i.e., Ginkgo Bioworks and Silence Therapeutics go up and down completely randomly.

Pair Corralation between Ginkgo Bioworks and Silence Therapeutics

Considering the 90-day investment horizon Ginkgo Bioworks Holdings is expected to under-perform the Silence Therapeutics. In addition to that, Ginkgo Bioworks is 1.17 times more volatile than Silence Therapeutics PLC. It trades about -0.03 of its total potential returns per unit of risk. Silence Therapeutics PLC is currently generating about -0.01 per unit of volatility. If you would invest  1,540  in Silence Therapeutics PLC on September 12, 2024 and sell it today you would lose (857.00) from holding Silence Therapeutics PLC or give up 55.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ginkgo Bioworks Holdings  vs.  Silence Therapeutics PLC

 Performance 
       Timeline  
Ginkgo Bioworks Holdings 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ginkgo Bioworks Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ginkgo Bioworks sustained solid returns over the last few months and may actually be approaching a breakup point.
Silence Therapeutics PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silence Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ginkgo Bioworks and Silence Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ginkgo Bioworks and Silence Therapeutics

The main advantage of trading using opposite Ginkgo Bioworks and Silence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ginkgo Bioworks position performs unexpectedly, Silence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silence Therapeutics will offset losses from the drop in Silence Therapeutics' long position.
The idea behind Ginkgo Bioworks Holdings and Silence Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format